MALCHIODI Emilio Luis
Glycosylation-dependent binding of galectin-8 to activated leukocyte cell adhesion molecule (ALCAM/CD166) promotes its surface segregation on breast cancer cells.
FERNÁNDEZ MM; FERRAGUT F; CÁRDENAS DELGADO VM; BRACALENTE C; BRAVO AI; CAGNONI AJ; NUÑEZ M; MOROSI LG; QUINTA HR; ESPELT MV; TRONCOSO MFS; WOLFENSTEIN-TODEL CS; MARIÑO KV; MALCHIODI EMILIO LUIS ; RABINOVICH GAS; ELOLA MTS
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
ELSEVIER SCIENCE BV
Lugar: Amsterdam; Año: 2016 vol. 1860 p. 2255 - 2268
AbstractBACKGROUND:We previously demonstrated that the activated leukocyte cell adhesion molecule (ALCAM/CD166) can interact with galectin-8 (Gal-8) in endothelial cells. ALCAM is a member of the immunoglobulin superfamily that promotes homophilic and heterophilic cell-cell interactions. Gal-8 is a "tandem-repeat"-type galectin, known as a matricellular protein involved in cell adhesion. Here, we analyzed the physical interaction between both molecules in breast cancer cells and the functional relevance of this phenomenon.METHODS:We performed binding assays by surface plasmon resonance to study the interaction between Gal-8 and the recombinant glycosylated ALCAM ectodomain or endogenous ALCAM from MDA-MB-231 breast cancer cells. We also analyzed the binding of ALCAM-silenced or control breast cancer cells to immobilized Gal-8 by SPR. In internalization assays, we evaluated the influence of Gal-8 on ALCAM surface localization.RESULTS:We showed that recombinant glycosylated ALCAM and endogenous ALCAM from breast carcinoma cells physically interacted with Gal-8 in a glycosylation-dependent fashion displaying a differential behavior compared to non-glycosylated ALCAM. Moreover, ALCAM-silenced breast cancer cells exhibited reduced binding to Gal-8 relative to control cells. Importantly, exogenously added Gal-8 provoked ALCAM segregation, probably trapping this adhesion molecule at the surface of breast cancer cells.CONCLUSIONS:Our data indicate that Gal-8 interacts with ALCAM at the surface of breast cancer cells through glycosylation-dependent mechanisms.GENERAL SIGNIFICANCE:A novel heterophilic interaction between ALCAM and Gal-8 is demonstrated here, suggesting its physiologic relevance in the biology of breast cancer cells.